Oxymycine LA 300 (Canada)This page contains information on Oxymycine LA 300 for veterinary use.
The information provided typically includes the following:
- Oxymycine LA 300 Indications
- Warnings and cautions for Oxymycine LA 300
- Direction and dosage information for Oxymycine LA 300
Oxymycine LA 300This treatment applies to the following species:
STERILE INJECTABLE SOLUTION
Veterinary Use Only
A long acting broad spectrum antibiotic.
Active Ingredient per mL:
Oxytetracycline dihydrate BP equivalent to 300 mg oxytetracycline base.
Antioxidant: Sodium Formaldehyde Sulphoxylate.
OXYMYCINE LA 300 Injectable Solution is specially formulated to provide sustained antibiotic blood levels up to 4 days in cattle and pigs following a single treatment.
OXYMYCINE LA 300 Injectable Solution is a sterile, long acting stable aqueous solution containing oxytetracycline dihydrate equivalent to 300 mg oxytetracycline base per mL.
OXYMYCINE LA 300 Injectable Solution offers the advantage of combining broad spectrum effectiveness against both gram positive and gram negative bacteria, with prolonged antibiotic blood levels up to 4 days duration following a single treatment.
Oxymycine LA 300 Indications
OXYMYCINE LA 300 Injectable Solution is indicated in the treatment of all infections caused by oxytetracycline susceptible bacteria in cattle and pigs.
CATTLE: Bacterial pneumonia, Pasteurellosis (associated with shipping fever complex), Mastitis, Metritis, Calf Scours (bacterial enteritis), Foot Rot, Navel ill, Calf Diphtheria, Leptospirosis, Blackleg/Malignant Edema, Peritonitis, Joint ill.
SWINE: Erysipelas, Bacterial enteritis, Leptospirosis, Metritis, Mastitis, Bacterial pneumonia.
Dosage and Administration
For intramuscular or subcutaneous administration to cattle and intramuscular administration to pigs at a single dose rate of 1 mL per 15 kg of live bodyweight (20 mg oxytetracycline per kg bodyweight).
It is recommended that the maximum dose at any one site is 10 mL in cattle and 5 mL in pigs to minimize local tissue irritation at the injection site. Intramuscular injections should be made deep into the fleshy part of the muscle such as the neck. Subcutaneous injections should be administered in the neck region.
Following administration, temporary localized swelling may be observed at the site of injection for several days. This is due to the high concentration and long acting effect of the product.
OXYMYCINE LA 300 Injectable Solution should be warmed to body temperature prior to administration.
If clinical improvement is not observed after 48 hours, clinical re-evaluation may be required. In non-responsive cases, consideration may be given to the use of an alternative antibiotic.
Note: Treatment with OXYMYCINE LA 300 only, in severe disease cases, may be insufficient.
Treated animals must not be slaughtered for use in food for at least 21 days after the latest treatment with this drug. Do not use in lactating dairy cattle.
Treated cattle must not be slaughtered for use in food for at least 42 days after the latest treatment with this drug. Do not use in lactating dairy cattle.
Note: To avoid the possibility of excessive trim at the site of injection, do not slaughter cattle for at least 42 days after the latest treatment with this drug.
Occasional hypersensitivity reactions (anaphylaxis) have been observed following the parenteral administration of oxytetracycline. If such side effects occur, discontinue use of the drug and administer epinephrine immediately. The safety of this product in pregnant animals has not been demonstrated.
Store between 15 and 25°C. Protect from light.
Do not freeze.
OXYMYCINE LA 300 Injectable Solution is available in multidose 250 mL and 500 mL vials.
Zoetis is a trademark of Zoetis or its licensors, used under license by Zoetis Canada Inc.
Zoetis Canada Inc., Kirkland QC H9H 4M7
NAC No.: 1198434.2
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
|Technical Services Canada:||800-461-0917|
|Technical Services USA:||800-366-5288|
|Every effort has been made to ensure the accuracy of the Oxymycine LA 300 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06